Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05064540 · ClinicalTrials.gov registry record · NA
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
A NA study of AAA - Abdominal Aortic Aneurysm and AAA, sponsored by Endologix.
- Recruiting
- Registry status
- NA
- Development phase
- 450
- Enrollment target
- 20
- Study locations
NCT05064540 is a NA study of AAA - Abdominal Aortic Aneurysm and AAA that is actively recruiting participants, run by Endologix. The registered enrollment target is 450 participants. The trial reports 20 study locations across 14 states.
The verdict
NCT05064540, a NA study of AAA - Abdominal Aortic Aneurysm and AAA, is actively recruiting participants, sponsored by Endologix.
- RECRUITING
- Registry status
- NA
- Development phase
- 450 participants
- Enrollment target
- 20
- Study locations
Study Summary
Prospective, randomized, multi-center study designed to evaluate the outcomes of commercially available contemporary EVAR in a real-world population. Patients will be randomized into two device cohorts and compared across the primary endpoints. Patients will be followed procedurally to discharge, at 1, 6, 12 months and annually through to 5 years (total follow-up commitment).
Conditions Studied
Interventions
- DEVICE Alto Abdominal Stent Graft System
- DEVICE FDA Approved EVAR AAA Graft Systems
Study Locations (20)
Florida
- Jacksonville Center for Clinical Research - Jacksonville
- Radiology and Imaging Specialists - Lakeland
- Baptist Hospital of Miami, Miami Cardiac and Vascular Institute - Miami
Arkansas
- Washington Regional Medical Center - Fayetteville
- Central Arkansas Veterans Healthcare System - Little Rock
California
- The Regents of the University of California, San Diego - La Jolla
- Veterans Affairs San Diego Healthcare System - San Diego
New York
- Icahn School of Medicine at Mount Sinai - New York
- Feinstein Institutes for Medical Research (Staten Island University Hospital/Northwell Health) - Staten Island
Ohio
- The Cleveland Clinical Foundation - Cleveland
- The Ohio State University - Columbus
Alabama
- Huntsville Hospital - Huntsville
Arizona
- University of Arizona - Tucson
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2021-09-20 |
| Est. Completion | 2031-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05064540
The ClinicalTrials.gov registry entry for NCT05064540 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endologix, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with AAA - Abdominal Aortic Aneurysm appearing as the primary indexed condition, and to 2 interventions - of which Alto Abdominal Stent Graft System is the first listed.
NCT05064540 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Florida, Arkansas, California.
Frequently Asked Questions
What is clinical trial NCT05064540 about?
NCT05064540 is a clinical study titled "JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization". Prospective, randomized, multi-center study designed to evaluate the outcomes of commercially available contemporary EVAR in a real-world population. Patients will be randomized into two device cohorts and compared across the primary endpoints. Patients will be followed procedurally to discharge, a...
What is the current status of trial NCT05064540?
This trial is currently recruiting. It is a NA study. The enrollment target is 450 participants. The study started on 2021-09-20. Estimated completion is 2031-03.
What conditions does trial NCT05064540 study?
This clinical trial studies the following conditions: AAA - Abdominal Aortic Aneurysm, AAA.
What interventions are being tested in trial NCT05064540?
The interventions under investigation include: Alto Abdominal Stent Graft System (DEVICE), FDA Approved EVAR AAA Graft Systems (DEVICE).
Who is sponsoring clinical trial NCT05064540?
This trial is sponsored by Endologix, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05064540 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for AAA - Abdominal Aortic Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.